Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NBPF15 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | AVPI1 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | SUGT1 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
mRNA | LAMB2 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
mRNA | LDHA | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
mRNA | EIF2S2 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | PLEKHN1 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
mRNA | SH2D4A | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
mRNA | IQGAP1 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
mRNA | PLD2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |